 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | JCXH-212 / Immorna
Enrollment open, Metastases: Evaluate the Safety and Tolerability of JCXH-212 Injection in the Treatment of Advanced Malignant Solid Tumors (clinicaltrials.gov) - Apr 10, 2023
P1, N=24, Recruiting, Sponsor: Peking University Cancer Hospital & Institute
Not yet recruiting --> Recruiting
- | JCXH-212 / Immorna
New P1 trial, Metastases: Evaluate the Safety and Tolerability of JCXH-212 Injection in the Treatment of Advanced Malignant Solid Tumors (clinicaltrials.gov) - Oct 13, 2022
P1, N=24, Not yet recruiting, Sponsor: Peking University Cancer Hospital & Institute